Alverine test to lower high pressure in the liver
Part of Digestive system clinical trials.
This trial studies alverine to lower portal hypertension, which is high blood pressure in the liver that can happen with cirrhosis. If it works safely, it may reduce pressure-related complications in people with confirmed liver scarring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have confirmed cirrhosis (diagnosed on scan or liver biopsy)
- Your portal pressure is at least 10 mmHg
- You agree to take part by signing informed consent
- You have not taken non-selective beta-blockers or statins in the past month
- You do not have recent serious complications (like bleeding, major confusion, or major belly fluid buildup) in the past week
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, painless ultrasound method to check for high blood pressure in the liver's main blood vessel. It aims to avoid more invasive tests for people with cirrhosis. It might help doctors tell if you are at risk of bleeding without a catheter procedure.
This study is checking if it is safe for people with cirrhosis (liver scarring) to stop taking a certain blood pressure medicine (non-selective beta blockers) if their main liver problem is under control. If you've had varices or bleeding in the past and your liver is now stable, this trial will see if you can safely stop the medicine.
This study tests a medicine called carvedilol (a non-selective beta-blocker) to see if it can prevent complications in people with advanced chronic liver disease who are at high risk but haven't had serious problems like bleeding yet.
This trial studies better ways to use endoscopy and other treatments to stop bleeding in the stomach or esophagus caused by high blood pressure in the liver (portal hypertension). It may help if you have been diagnosed with portal hypertension and have varices (enlarged veins) in your esophagus or stomach.
This study tests whether adding alverine to carvedilol helps lower pressure in the liver's blood vessels in people with cirrhosis, which may reduce the risk of bleeding.
This trial tests whether a long-term medicine called carvedilol can prevent liver failure or death in people with early-stage cirrhosis and high pressure in the liver's blood vessels. It may help delay serious complications and improve outcomes.
Hear when a new Portal Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.